Examples of 'pegvisomant' in a sentence
Meaning of "pegvisomant"
pegvisomant (adjective): Pegvisomant is a term used in pharmacology to describe a type of medication or substance related to the drug with the same name, which is a growth hormone receptor antagonist
Show more definitions
- A growth hormone receptor antagonist used in the treatment of acromegaly.
How to use "pegvisomant" in a sentence
Basic
Advanced
pegvisomant
Pegvisomant is a potent antagonist of growth hormone action.
The metabolism of pegvisomant has not been studied.
There is limited experience of overdose with pegvisomant.
Treatment by pegvisomant does not reduce tumour size.
Somavert contains the active substance pegvisomant.
Pegvisomant should be administered by subcutaneous injection.
The metabolism of pegvisomant is not studied.
For pegvisomant no clinical data on exposed pregnancies are available.
The active substance is pegvisomant.
For pegvisomant no data on fertility are available.
Examples of growth hormone receptor antagonists include pegvisomant and the like.
It is not known if pegvisomant passes into breast milk.
Pegvisomant is a growth hormone antagonist.
SOMAVERT powder for solution for injection Pegvisomant Subcutaneous use.
Administration of pegvisomant should be discontinued if signs of liver disease persist.
See also
Somavert powder in vial with solvent in a pre-filled syringe pegvisomant for injection.
Pegvisomant obstructs the side effects of growth hormone release.
If you are allergic ( hypersensitive ) to pegvisomant or any of the other ingredients of SOMAVERT.
Pegvisomant for injection.
The active substance in SOMAVERT, pegvisomant is known as a growth hormone receptor antagonist.
Pegvisomant blocks the effects of excess growth hormone production on the body.
What SOMAVERT contains - The active substance is pegvisomant.
The excretion of pegvisomant in breast milk has not been studied in animals.
A newer therapy is the growth hormone receptor blocker pegvisomant ( FDA pregnancy category B ).
Clearance of pegvisomant following multiple doses is lower than seen following a single dose.
SOMAVERT 10 mg powder for solution for injection pegvisomant.
Pegvisomant is slowly eliminated from serum, with.
SOMAVERT 10 mg powder and solvent for solution for injection pegvisomant.
A loading dose of 80 mg pegvisomant should be administered subcutaneously under medical supervision.
SOMAVERT 10 mg powder and solvent for solution for injection One vial contains 10 mg of pegvisomant.
Pegvisomant works by blocking the action of growth hormone on your body 's cells.
SOMAVERT 10 mg powder for injection pegvisomant.
Renal clearance of pegvisomant is negligible and accounts for less than 1 % of total body clearance.
SOMAVERT 10 mg powder for solution for injection Pegvisomant Subcutaneous use.
Pegvisomant binds to the GH receptor, therefore, blocking GH binding since the receptor is occupied.
After reconstitution, 1 ml of solution contains 10 mg pegvisomant.
Pegvisomant ( trade name Somavert ) is a growth hormone receptor antagonist used in the treatment of acromegaly.
The apparent volume of distribution of pegvisomant is relatively small 7-12 l.
Therefore, pegvisomant should not be used in breast-feeding women.
Ml of solvent, 1 ml of the solution contains 20 mg pegvisomant.
Characterization Pegvisomant contains 191 amino acid residues to which polyethylene glycol ( PEG ) polymers are covalently bound.
After reconstitution with 1 ml of solvent, 1 ml of the solution contains 10 mg pegvisomant.
Pegvisomant is not recommended during pregnancy see section 4.6.
One vial contains 10 mg pegvisomant.
After single subcutaneous pegvisomant administration no linearity is observed with rising doses of 10, 15 or 20 mg.
Each vial contains 10 mg of pegvisomant.
One vial contains 20 mg pegvisomant After reconstitution, 1 ml of solution contains 20 mg pegvisomant.
Pegvisomant ( Somavert ® ; Pharmacia Corp. ) is a human growth hormone receptor antagonist.
The molecular weight of each PEG unit of pegvisomant is approximately 5000 Daltons.
